TABLE 7.
Setting 2, : Measures of size of the trial across scenarios, total duration in weeks, and total number of patients
| TITE‐CRM | TITE‐CRM2 | ICSDP | POMM | nTTP | TITE‐BOIN | TITE‐mTPI2 | R‐mTPI2 | |
|---|---|---|---|---|---|---|---|---|
| Scenario | Mean duration in weeks (SD) | |||||||
| C | 28 (9) | 24 (8) | 38 (12) | 31 (10) | 24 (3) | 16 (11) | 22 (14) | 21 (17) |
| D | 54 (10) | 53 (10) | 53 (8) | 43 (4) | 29 (5) | 43 (8) | 73 (17) | 92 (22) |
| E | 40 (11) | 37 (12) | 42 (10) | 41 (9) | 30 (4) | 33 (15) | 42 (20) | 47 (26) |
| F | 57 (13) | 55 (14) | 54 (12) | 44 (6) | 33 (6) | 56 (15) | 79 (31) | 86 (34) |
| Mean | 45 | 42 | 47 | 40 | 29 | 37 | 54 | 61 |
| Scenario | Mean number of patients (SD) | |||||||
| C | 9 (3) | 7 (3) | 14 (5) | 10 (4) | 6 (1) | 8 (5) | 7 (4) | 7 (4) |
| D | 21 (5) | 21 (5) | 21 (4) | 16 (2) | 10 (2) | 21 (4) | 20 (5) | 19 (4) |
| E | 14 (5) | 12 (6) | 15 (5) | 15 (5) | 9 (2) | 16 (7) | 13 (5) | 13 (6) |
| F | 22 (7) | 22 (7) | 21 (6) | 16 (3) | 11 (3) | 26 (5) | 20 (7) | 20 (6) |
| Mean | 17 | 15 | 18 | 14 | 9 | 18 | 15 | 15 |